Search Results
1
Study Matches
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of CC-220 in Subjects with Active Systemic Lupus Erythematosus
This study is for patients with SLE (systemic lupus erythematosus) to determine the effectiveness and safety of drug CC-220 on improving SLE and to see how well the body tolerates the medication.
Jamie Carter at jcarter3@pennstatehealth.psu.edu or 717-531-0003, ext=283833
All
18 year(s) or older
NCT03161483
Infectious Diseases & Immune System, Arthritis & Rheumatic Diseases, Muscle & Bone